Endohepatology – Current View

### **Endohepatology – Current View**

Endohepatology is an emerging and innovative field that integrates endoscopic ultrasound (EUS)-based diagnostic and therapeutic interventions into hepatology practice. This approach is revolutionizing the management of liver diseases by expanding the scope of traditional endoscopy beyond procedures like variceal ligation. By combining hepatology and advanced endoscopic techniques, endohepatology is streamlining care, improving diagnostic accuracy, and offering minimally invasive therapeutic options for a wide range of liver-related conditions. Below is a detailed overview of the current state of endohepatology:

---

### **Key Components and Applications**

#### **1. Streamlined Care**

• **Efficiency:** Endohepatology allows for multiple diagnostic and therapeutic procedures to be performed in a single session, reducing the need for multiple hospital visits. Examples include:
• Variceal surveillance
• EUS-guided liver stiffness assessment
• Targeted liver biopsy
• **Patient Satisfaction:** This streamlined approach enhances patient convenience and reduces procedural burden.

#### **2. EUS-Guided Liver Biopsy (EUS-LBx)**

• **Minimally Invasive Alternative:** EUS-LBx is gaining popularity over traditional percutaneous liver biopsy due to its ability to sample both liver lobes under Doppler guidance, minimizing the risk of vascular injury.
• **Biopsy Quality:**
• Optimal biopsy cores require a length of ≥20 mm and ≥11 complete portal tracts.
• Studies show that 19G needles and wet suction techniques provide better adequacy compared to smaller or dry needles.
• **Diagnostic Accuracy:**
• Meta-analyses report diagnostic adequacy rates of ~88% for EUS-LBx compared to ~98% for percutaneous biopsy. However, newer techniques are narrowing this gap.

#### **3. Targeted Lesion Biopsy**

• **Precision:** EUS enables targeted sampling of focal liver lesions, particularly those located in challenging areas like the left lobe.
• **Sensitivity:** High sensitivity for detecting hepatocellular carcinoma (HCC) and liver metastases, making it a valuable tool for oncological diagnosis.

#### **4. Variceal Management**

• **EUS-Guided Coil and Glue Injection:**
• Safer and more effective therapy for gastric varices compared to direct injection.
• Reduces rebleeding rates and procedural risks.
• **Clinical Success of Coil Therapy:**
• Large multicenter studies report >90% obliteration of gastric varices and <5% post-therapy bleeding.
• Outperforms cyanoacrylate injection alone.
• **Esophageal Variceal Bleeding:**
• For refractory cases, EUS and self-expanding metal stents (SEMS) are emerging alternatives to balloon tamponade, offering better hemostasis and fewer complications.

#### **5. Transplant Applications**

• **Post-Transplant Support:** Endoscopy plays a crucial role in managing liver transplant patients through:
• ERCP for biliary strictures and leaks.
• EUS for post-transplant liver biopsies.
• **Streamlined Diagnosis:** Same-session ERCP and EUS biopsy streamline evaluations, reducing time to diagnosis and treatment.

#### **6. EUS in Ascites**

• **Enhanced Detection:** EUS detects ascites more sensitively than imaging modalities like ultrasound or CT.
• **Fluid Aspiration:** Enables cytological and infection testing, particularly valuable in cases where malignancy is suspected.

#### **7. EUS for Liver Abscess**

• **Drainage:** In select cases, such as left lobe abscesses, EUS-guided drainage offers:
• Faster symptom resolution
• Fewer complications
• Shorter hospital stays compared to percutaneous drainage.

#### **8. EUS-Guided Elastography (EUS-SWE)**

• **Advanced Fibrosis Staging:** Measures liver stiffness more accurately in patients with obesity or ascites, outperforming traditional methods like FibroScan or FIB-4.
• **Clinical Impact:** Provides superior staging of liver fibrosis, aiding in disease management.

#### **9. Portal Venous Sampling**

• **Prognostic Insights:** EUS enables portal vein sampling to analyze circulating tumor cells (CTCs), offering valuable prognostic information in gastrointestinal cancers.
• **Research Potential:** May provide insights into microbiome and metabolomics for future therapeutic applications.

#### **10. Experimental Tumor Therapies**

• **Innovative Approaches:** EUS-guided delivery of experimental therapies for HCC and metastases is under investigation, including:
• Ethanol injection
• Chemotherapy microbeads
• Radiofrequency ablation
• Gene therapy

#### **11. Portal Pressure Gradient (EUS-PPG)**

• **Direct Measurement:** EUS-PPG directly measures portal hypertension and demonstrates strong correlation with the gold standard hepatic venous pressure gradient (HVPG).
• **Technical Success:** ~95% success rate with minimal adverse events.

#### **12. EUS Portosystemic Shunts**

• **Animal Studies:** Feasibility of creating portosystemic shunts with lumen-apposing stents mimicking transjugular intrahepatic portosystemic shunt (TIPS).
• **Challenges:** Issues like thrombosis need to be resolved before clinical application.

#### **13. Endobariatrics Integration**

• **MASLD (Metabolic Associated Steatotic Liver Disease):** Endoscopic bariatric therapies like ESG (endoscopic sleeve gastroplasty) and TORe (transoral outlet reduction) show:
• Significant weight loss
• Reduced fibrosis scores
• Improved portal pressures
• **Combination Therapies:** ESG combined with GLP-1 agonists yields greater weight loss and fibrosis reduction compared to endoscopy alone, highlighting synergy between endoscopic and pharmacologic approaches.

---

### **Future Outlook**

Endohepatology is rapidly evolving as a multidisciplinary field with immense potential to transform hepatology practice. While several interventions, such as coil therapy for varices and EUS elastography, have already demonstrated clinical impact, others remain experimental and require further validation. Key areas of ongoing research and development include:

• Refining techniques for EUS-guided liver biopsy to match or exceed the diagnostic adequacy of percutaneous biopsy.
• Advancing experimental tumor therapies for HCC and metastases.
• Addressing technical challenges in creating EUS-guided portosystemic shunts.
• Expanding the integration of endobariatrics into MASLD management.

As technology and research progress, endohepatology is expected to become a cornerstone of liver disease management, offering minimally invasive, highly effective solutions for diagnosis and treatment.